Company profile
Home - EMQN
We are a not-for-profit organisation promoting quality in genetic testing by establishing, harmonising and disseminating best practice.
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
CS01 | Transaction MzUyNTg2MTE0MmFkaXF6a2N4
Published 08 Jun 2026 12:39
Last confirmation statement made up date
Last accounts made up date
TM01 | Transaction MzQ0NDMyODkxOGFkaXF6a2N4
Published 20 Nov 2024 10:48
AA | Transaction MzQzNzAyNzExN2FkaXF6a2N4 | Paper/PDF filed
Published 29 Sep 2024 05:48
Company registered at Companies House
1 Apr 2025 to 31 Mar 2026
The DEVOTE programme is helping to bring cutting-edge genetic testing into everyday healthcare in Greater Manchester. By combining expertise from universities, hospitals, and businesses, it has already started improving patient care by making genetic testing a routine part of diagnosis and treatment. The next phase of DEVOTE will continue working with ind...
1 Apr 2023 to 31 Mar 2025
A biomarker is a chemical or signal which can be measured from the human body to help to diagnose disease or predict future health states. Biomarkers are commonly used in healthcare to guide patient management, but there is a major translational bottleneck between the discovery of a clinically relevant biomarker and its implementation in routine practice ...
